Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Immunologic basis of cardiovascular disease in HIV-infected adults.

Hsue PY, Deeks SG, Hunt PW.

J Infect Dis. 2012 Jun;205 Suppl 3:S375-82. doi: 10.1093/infdis/jis200. Review.

2.

[Inflammation and HIV].

Bricaire F, Valantin MA.

Bull Acad Natl Med. 2011 Mar;195(3):531-42; discussion 543-4. Review. French.

PMID:
22292303
3.

Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals.

Lacerda HR, Falcão Mda C, de Albuquerque VM, Zírpoli JC, Miranda-Filho Dde B, de Albuquerque Mde F, Montarroyos U, Ximenes RA.

J Interferon Cytokine Res. 2014 May;34(5):385-93. doi: 10.1089/jir.2013.0029. Epub 2013 Dec 20.

PMID:
24359573
4.

Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.

Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA.

Vasc Health Risk Manag. 2015 Jan 6;11:35-48. doi: 10.2147/VHRM.S65885. eCollection 2015. Review.

5.

HIV infection, inflammation, immunosenescence, and aging.

Deeks SG.

Annu Rev Med. 2011;62:141-55. doi: 10.1146/annurev-med-042909-093756. Review.

6.

Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.

Syed SS, Balluz RS, Kabagambe EK, Meyer WA 3rd, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):493-500. doi: 10.1089/AID.2012.0086. Epub 2012 Dec 3.

7.

Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.

Bhatia R, Ryscavage P, Taiwo B.

J Neurovirol. 2012 Aug;18(4):247-55. doi: 10.1007/s13365-011-0073-y. Epub 2011 Dec 29. Review.

PMID:
22205585
8.

The role of T cells in the development of cardiovascular disease in HIV-infected patients.

Krikke M, van Lelyveld SF, Tesselaar K, Arends JE, Hoepelman IM, Visseren FL.

Atherosclerosis. 2014 Nov;237(1):92-8. doi: 10.1016/j.atherosclerosis.2014.08.054. Epub 2014 Sep 6. Review.

PMID:
25238214
9.

Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.

Gresele P, Falcinelli E, Momi S, Francisci D, Baldelli F.

Rev Cardiovasc Med. 2014;15 Suppl 1:S9-20. Review.

PMID:
24987863
10.

Cardiovascular disease and HIV infection: host, virus, or drugs?

Martínez E, Larrousse M, Gatell JM.

Curr Opin Infect Dis. 2009 Feb;22(1):28-34. doi: 10.1097/QCO.0b013e328320a849. Review.

PMID:
19532078
11.

Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

Martin-Iguacel R, Llibre JM, Friis-Moller N.

Curr HIV/AIDS Rep. 2015 Dec;12(4):375-87. doi: 10.1007/s11904-015-0284-6. Review.

PMID:
26423407
12.

HIV-related mechanisms in atherosclerosis and cardiovascular diseases.

Gibellini D, Borderi M, Clò A, Morini S, Miserocchi A, Bon I, Ponti C, Re MC.

J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):780-90. doi: 10.2459/JCM.0b013e3283619331. Review.

PMID:
23656915
13.

The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction.

Towner WJ, Xu L, Leyden WA, Horberg MA, Chao CR, Tang B, Klein DB, Hurley LB, Quesenberry CP Jr, Silverberg MJ.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):321-7. doi: 10.1097/QAI.0b013e31824e9ef2.

14.

Circulating endothelial progenitor cells in HIV infection: a systematic review.

Costiniuk CT, Hibbert BM, Simard T, Ghazawi FM, Angel JB, O'Brien ER.

Trends Cardiovasc Med. 2013 Aug;23(6):192-200. doi: 10.1016/j.tcm.2012.12.002. Epub 2013 Feb 8. Review.

PMID:
23395428
15.

Antiretroviral molecules and cardiovascular diseases.

Gibellini D, Borderi M, Clò A, Morini S, Miserocchi A, Bon I, Re MC.

New Microbiol. 2012 Oct;35(4):359-75. Epub 2012 Oct 1. Review.

16.
17.

Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects.

Wallet MA, Buford TW, Joseph AM, Sankuratri M, Leeuwenburgh C, Pahor M, Manini T, Sleasman JW, Goodenow MM.

BMC Immunol. 2015 Jul 24;16:43. doi: 10.1186/s12865-015-0106-z.

18.

Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virus.

Schafer JJ, Short WR, Squires KE.

Pharmacotherapy. 2010 Oct;30(10):1072-83. doi: 10.1592/phco.30.10.1072.

PMID:
20874044
19.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
20.

HIV infection, antiretroviral therapy and cardiovascular risk.

Barbaro G.

J Cardiovasc Risk. 2002 Oct;9(5):295-300. Review.

PMID:
12394324

Supplemental Content

Support Center